MeSH tree: D12.776.631.650.300
New research presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey (12–15 May) and published in Nature Medicine shows that most weight loss achieved using the injectable obesity drugs tirzepatide or ...
May 13, 2026
0
7
New research presented at the European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12–15 May) and published in The Lancet shows that people who have lost weight using the maximum tolerated dose (MTD) of tirzepatide ...
May 13, 2026
0
20
New research presented at the European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12–15 May) shows that, following treatment for obesity or diabetes or both, using incretin-based drugs, losing more weight versus less ...
May 9, 2026
0
8
Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month. It's a notable shift for Medicare, which has long been barred from covering weight loss treatments.
May 8, 2026
0
13
Annual medical checkups typically cover the basics: diet, exercise and mental state. Surprisingly, many primary care providers fail to ask about one of the fundamental contributors to well-being: sleep.
May 6, 2026
0
11
Inconsistent use of some GLP-1 weight-loss medications, like Ozempic and Wegovy, may significantly lessen their effectiveness, according to a new preclinical study from researchers at the Perelman School of Medicine at the ...
May 3, 2026
0
10
As many of us know, keeping weight in check can be hard. National numbers certainly reflect this. Rates of overweight and obesity in the U.S. have steadily climbed since the early 1980s. The impact this has had on health ...
Apr 29, 2026
0
14
An outpatient procedure may offer a way for the estimated 70% of people who discontinue popular weight-loss drugs to avoid regaining the pounds they shed, according to a study presented at Digestive Disease Week (DDW) 2026.
Apr 23, 2026
0
12
A new UNC School of Medicine study of incretin-based medications, including newer medications such as semaglutide and tirzepatide that are widely prescribed for type 2 diabetes and obesity, finds they are associated with ...
Apr 17, 2026
0
19
A new approach to weight loss research is challenging one of the biggest assumptions behind popular weight loss drugs: Are GLP-1s actually needed to achieve weight loss?
Apr 17, 2026
0
35
